In a field riddled with a “long list of failures,” as Reuters reported, small companies Athersys and Mesoblast are pushing forward with stem cell therapies that could be potentially life-changing for stroke and heart failure patients, as well as their practitioners.

Researchers at UCLA have developed a blood test using gene activity data from immune cells that helps predict the survival of advanced heart failure patients receiving mechanical circulatory support (MCS) devices.

Children and adolescents who are abused, bullied, experience economic hardship or witness violence are more likely to develop cardiovascular disease as adults, according to scientific statement published Dec. 18 in Circulation.

Since the late ’60s, menopausal hormone therapy has been touted as not just a tool for alleviating menopausal discomfort but as a way to preemptively protect women against cardiovascular disease, cancer and stroke.

One-third of diabetic patients prescribed metformin—the mostly commonly recommended diabetes drug—aren’t taking the medication due to side effects ranging from diarrhea to depression, researchers in the United Kingdom have found.

Life expectancy is declining for American women, according to a recent CBS report—and it’s mostly due to preventable disease.

Erectile dysfunction could be an early warning sign of subclinical cardiovascular disease (CVD), especially in young men whose CVD risks aren’t steadily monitored, researchers reported in Vascular Medicine this December.

A blood test for high-sensitivity troponin T (hsTnT) used in emergency departments successfully ruled out myocardial infarction (MI) and helped identify patients at low 30-day risk for adverse cardiac events, researchers reported in JAMA Cardiology.